PJ

Preeti Jain

Active Director Additional Director DIN 09429106
DIN 09429106 First appointment May 2024 Primary industry Information Technology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Preeti Jain

Data last updated:

Preeti Jain is an Additional Director at Mediliant Life Science Private Limited (since 2024). The company operates in Information Technology.

DIN 09429106
Primary Designation Additional Director
Industry Information Technology
First Appointment 21 May 2024
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director21 May 20242019Active

Board colleagues of Preeti Jain

Directorship timeline

Open interactive timeline →
Mediliant Life Science Private Limited
Premium access

Shareholding and investment profile for Preeti Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Preeti Jain

Preeti Jain currently holds 1 directorship: Mediliant Life Science Private Limited (Additional Director, since 21 May 2024).

Preeti Jain was first appointed on 21 May 2024 as Additional Director at Mediliant Life Science Private Limited.

The current boards of Preeti Jain's companies include Nitesh Jain (Mediliant Life Science Private Limited), Nitin Garg (Mediliant Life Science Private Limited), Sonam Garg (Mediliant Life Science Private Limited), Sushila Garg (Mediliant Life Science Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available